[HTML][HTML] Current status and future direction of metallic and polymeric materials for advanced vascular stents
Cardiovascular disease (CVD) has emerged as a severe illness worldwide. Currently, the
top ten causes of death in the world include ischemic heart disease according to the Global …
top ten causes of death in the world include ischemic heart disease according to the Global …
Interpreting the results of cost-effectiveness studies
DJ Cohen, MR Reynolds - Journal of the American College of Cardiology, 2008 - jacc.org
In developed nations, health care spending is an increasingly important economic and
political issue. The discipline of cost-effectiveness (CE) analysis has developed over several …
political issue. The discipline of cost-effectiveness (CE) analysis has developed over several …
The pathophysiology and burden of restenosis
WS Weintraub - The American journal of cardiology, 2007 - Elsevier
The introduction of percutaneous transluminal coronary angioplasty (PTCA) revolutionized
the surgical treatment of coronary artery disease. However, despite increased surgical …
the surgical treatment of coronary artery disease. However, despite increased surgical …
Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month …
HP Brunner-La Rocca, C Kaiser, A Bernheim… - the Lancet, 2007 - thelancet.com
Background Our aim was to determine whether drug-eluting stents are good value for
money in long-term, everyday practice. Methods We did an 18-month cost-effectiveness …
money in long-term, everyday practice. Methods We did an 18-month cost-effectiveness …
Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model
P Garg, DJ Cohen, T Gaziano, L Mauri - Journal of the American College of …, 2008 - jacc.org
Objectives: We sought to define what incremental risk of very late stent thrombosis (VLST) in
drug-eluting stents (DES) would outweigh the restenosis benefit. Background: Although …
drug-eluting stents (DES) would outweigh the restenosis benefit. Background: Although …
Economic outcomes of percutaneous coronary intervention with drug‐eluting stents versus bypass surgery for patients with left main or three‐vessel coronary artery …
Objectives: To evaluate the cost‐effectiveness of alternative approaches to revascularization
for patients with three‐vessel or left main coronary artery disease (CAD). Background …
for patients with three‐vessel or left main coronary artery disease (CAD). Background …
A framework for the evaluation of “value” and cost-effectiveness in the management of critical limb ischemia
NR Barshes, M Belkin… - Journal of the …, 2011 - journals.lww.com
The problem of critical limb ischemia Peripheral arterial disease refers to the problem of
impaired arterial circulation to the lower extremities (specifically, an ankle-brachial index of …
impaired arterial circulation to the lower extremities (specifically, an ankle-brachial index of …
Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III …
EL Eisenstein, MB Leon, DE Kandzari, L Mauri… - JACC: Cardiovascular …, 2009 - jacc.org
Objectives: The aim of this study was to evaluate clinical and economic outcomes for
subjects receiving zotarolimus-eluting (ZES)(n= 323) versus sirolimus-eluting stents …
subjects receiving zotarolimus-eluting (ZES)(n= 323) versus sirolimus-eluting stents …
Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial …
EL Eisenstein, W Wijns, J Fajadet, L Mauri… - JACC: Cardiovascular …, 2009 - jacc.org
Objectives: This study was designed to evaluate long-term clinical and economic outcomes
for subjects receiving Endeavor drug-eluting versus Driver bare-metal stents (both Medtronic …
for subjects receiving Endeavor drug-eluting versus Driver bare-metal stents (both Medtronic …
[HTML][HTML] Comparison of clinical outcomes in patients undergoing coronary intervention with drug-eluting stents or bare-metal stents: a nationwide population study
Background The aim of this propensity score-matched cohort study was to investigate the
prognostic impacts of drug-eluting stents (DES) and bare-metal stents (BMS) in patients …
prognostic impacts of drug-eluting stents (DES) and bare-metal stents (BMS) in patients …